A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Adjunctive Brivaracetam in Asian Subjects (≥16 to 80 Years of Age) With Partial Seizures With or Without Secondary Generalization

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Adjunctive Brivaracetam in Asian Subjects (≥16 to 80 Years of Age) With Partial Seizures With or Without Secondary Generalization

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Brivaracetam (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors UCB Biopharma
  • Most Recent Events

    • 27 Jul 2017 Planned initiation date changed from 14 Jul 2017 to 14 Aug 2017.
    • 22 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top